Join
Live feed
·
INSIDERFilingvia Quantisnow
4D Molecular Therapeutics Inc. logo

Officer Kirn David sold $274,596 worth of shares (26,842 units at $10.23) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 844,895 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
FDMT· 4D Molecular Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FDMT (4D Molecular Therapeutics Inc.) and more on Quantisnow.